載入...
DOAC‐Stop in lupus anticoagulant testing: Direct oral anticoagulant interference removed in most samples
BACKGROUND: The use of direct oral anticoagulants (DOACs) is a convenient therapeutic option for patients at risk of thrombosis. DOACs interfere with clot‐based testing for the identification of lupus anticoagulant antibodies (LACs) in patients with antiphospholipid syndrome (APS), a common cause of...
Na minha lista:
| 發表在: | Res Pract Thromb Haemost |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7938630/ https://ncbi.nlm.nih.gov/pubmed/33733031 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/rth2.12472 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|